• Eur. J. Intern. Med. · Oct 2011

    Comparative Study

    Attitude of Swiss physicians towards opioid-induced constipation: a national survey.

    • Bernhard Hess, Marco Bernardi, and Hans-Peter Klotz.
    • Department of Internal Medicine & Nephrology, Klinik Im Park, Bellariastrasse 38, CH-8038 Zurich, Switzerland.
    • Eur. J. Intern. Med. 2011 Oct 1;22(5):527-31.

    BackgroundOpioid-induced constipation is a severe complication affecting up to 90% of chronic pain patients treated with opioids, causing considerable suffering and non-adherence to treatment.ObjectiveTo examine the attitude of Swiss practising physicians towards opioid-induced constipation awareness and management.MethodsA total of 961 Swiss practising physicians were surveyed by questionnaire concerning their experience of and perspective on the prevalence and symptoms of opioid-induced constipation, time of development, treatment, impact on quality of life (QoL) and adherence to opioid treatment. Chronic constipation was defined following the Rome III diagnostic criteria for functional gastrointestinal disorders.ResultsPhysicians stated that in their experience 62.4% (range 4-100%) of patients treated with opioids developed opioid-induced constipation and 82.4% of physicians observed it within the first week of opioid administration. Dry and/or hard stools were reported by 78.5% of physicians as the most prevalent observed symptom of opioid-induced constipation, 71.2% of physicians experienced a negative impact of opioid-induced constipation on the QoL of patients and 70.7% believed that opioid-induced constipation negatively affected patients' treatment adherence. Perceived efficacy was judged by 91.4% of physicians to be a highly relevant aspect of opioid therapy, whereas only 22.1% rated therapy costs as highly relevant.ConclusionSwiss physicians consider opioid-induced constipation to be a major and early developing adverse effect of opioid therapy that negatively affects QoL and treatment adherence. To avoid opioid-induced constipation, administration of laxatives or a combination of opioids with receptor antagonists must be considered as preventive measures.Copyright © 2011 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.